Pancreatic Cancer [clinicaltrials_resource:5f012ff3dda3c3498e5f2cb976e64caa]
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer [clinicaltrials:NCT00002475]Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer [clinicaltrials:NCT00002689]Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer [clinicaltrials:NCT00002773]Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas [clinicaltrials:NCT00002955]clinicaltrials:NCT00003018Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer [clinicaltrials:NCT00003025]Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas [clinicaltrials:NCT00003029]clinicaltrials:NCT00003046Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas [clinicaltrials:NCT00003049]Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer [clinicaltrials:NCT00003085]Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors [clinicaltrials:NCT00003125]clinicaltrials:NCT00003157Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas [clinicaltrials:NCT00003216]Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer [clinicaltrials:NCT00003332]Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer [clinicaltrials:NCT00003411]Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer [clinicaltrials:NCT00003426]Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer [clinicaltrials:NCT00003427]Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer [clinicaltrials:NCT00003434]Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer [clinicaltrials:NCT00003531]Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer [clinicaltrials:NCT00003546]clinicaltrials:NCT00003591clinicaltrials:NCT00003677Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer [clinicaltrials:NCT00003760]Perillyl Alcohol Followed by Surgery in Treating Patients With Stage II or Stage III Pancreatic Cancer [clinicaltrials:NCT00003769]Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas [clinicaltrials:NCT00003780]Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas [clinicaltrials:NCT00003797]Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery [clinicaltrials:NCT00003798]Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas [clinicaltrials:NCT00003810]Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer [clinicaltrials:NCT00003851]Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas [clinicaltrials:NCT00003923]DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas [clinicaltrials:NCT00003951]Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery [clinicaltrials:NCT00004003]Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer [clinicaltrials:NCT00004087]Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors [clinicaltrials:NCT00004095]clinicaltrials:NCT00004190clinicaltrials:NCT00004604Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer [clinicaltrials:NCT00004861]Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer [clinicaltrials:NCT00004879]Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer [clinicaltrials:NCT00004884]Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery [clinicaltrials:NCT00004895]
condition [clinicaltrials_vocabulary:condition]
eligibility for clinicaltrials:NCT01928394 [clinicaltrials_resource:10896edf7f8ce192744653721b03b3fc]eligibility for clinicaltrials:NCT00851955 [clinicaltrials_resource:1960f8b48308f7bce005b0f6e4647d84]eligibility for clinicaltrials:NCT00940225 [clinicaltrials_resource:f69f5aff457255724d0f2feb842463b3]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT01928394 [clinicaltrials_resource:10896edf7f8ce192744653721b03b3fc]eligibility for clinicaltrials:NCT00851955 [clinicaltrials_resource:1960f8b48308f7bce005b0f6e4647d84]eligibility for clinicaltrials:NCT00940225 [clinicaltrials_resource:f69f5aff457255724d0f2feb842463b3]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Pancreatic Cancer [clinicaltrials_resource:5f012ff3dda3c3498e5f2cb976e64caa]
Bio2RDF identifier
5f012ff3dda3c3498e5f2cb976e64caa
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5f012ff3dda3c3498e5f2cb976e64caa
identifier
clinicaltrials_resource:5f012ff3dda3c3498e5f2cb976e64caa
title
Pancreatic Cancer
@en
label
Pancreatic Cancer [clinicaltrials_resource:5f012ff3dda3c3498e5f2cb976e64caa]
@en